Skip to main content

Table 2 Convergent and divergent validity analysis with MP and reference measures (monthly sum scores)

From: Validation of a menstrual pictogram and a daily bleeding diary for assessment of uterine fibroid treatment efficacy in clinical studies

Spearman Rank Correlation Coefficient of MP monthly sum score to RND EOT
N rs N rs
UF-DBD monthly sum score 283 0.56 263 0.89
UF-DSD v3 monthly average bloating and swelling domain score 283 0.12 263 0.16
UF-DSD v3 monthly average pain domain score 283 0.06 263 0.27
UF-DSD v3 monthly average total scorea 283 0.10 263 0.21
UF-IS v3 monthly sum total score 263 0.21 247 0.35
UFS-QoL symptom domain score at visit 287 0.18 262 0.45
UFS-QoL HRQoL domain score at visit 282 −0.18 255 −0.41
UFS-QoL concerns related to soiling score at visit 282 0.20 257 0.51
SF-36 v2® physical component domain score at visit 278 −0.04 258 − 0.32
SF-36 v2® mental component domain score at visit 279 −0.12 258 −0.27
SF-36 v2® bodily pain subscale score at visit 286 −0.09 262 −0.31
  1. Classification of Spearman rank correlation coefficient rs: Weak correlation: 0.10 < |rs| < 0.30, Moderate correlation: 0.30 ≤ |rs| < 0.50, Strong correlation: 0.50 ≤ |rs| < 1
  2. All patients analyzed here had been enrolled in the ASTEROID 1 study with an existing date of visit
  3. EOT End of treatment, HRQoL Health-related quality of life, MP (MP SAP-c v3) Menstrual pictogram superabsorbent polymer-containing version 3, N Number of patients, RND Randomization, rs Spearman rank correlation coefficient, SF-36 v2® Short-Form 36 Health Survey Version 2, UF-DBD Uterine Fibroid Daily Bleeding Diary, UF-DSD v3 Uterine Fibroid Daily Symptom Diary version 3, UF-IS v3 Uterine Fibroid Impact Scale version 3, UFS-QoL Uterine Fibroid Symptom and Quality of Life Questionnaire
  4. aUF-DSD v3 total score with exclusion of item 1 (UF-DBD)